Sg Americas Securities, LLC Concert Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023
BUY
$4.34 - $5.84 $14,547 - $19,575
3,352 Added 19.71%
20,361 $119,000
Q3 2022

Oct 31, 2022
BUY
$4.27 - $7.2 $72,628 - $122,464
17,009 New
17,009 $114,000
Q3 2020

Nov 09, 2020
SELL
$8.67 - $10.82 $135,997 - $169,722
-15,686 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$7.8 - $11.52 $122,350 - $180,702
15,686 New
15,686 $156,000
Q4 2017

Jan 24, 2018
SELL
$13.96 - $29.05 $144,723 - $301,161
-10,367 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$13.91 - $15.31 $144,204 - $158,718
10,367
10,367 $153,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email